Illumina Stock Fundamentals
| ILMN Stock | USD 136.67 0.70 0.51% |
Illumina fundamentals help investors to digest information that contributes to Illumina's financial success or failures. It also enables traders to predict the movement of Illumina Stock. The fundamental analysis module provides a way to measure Illumina's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Illumina stock.
At this time, Illumina's Total Operating Expenses is very stable compared to the past year. As of the 18th of January 2025, Income Tax Expense is likely to grow to about 75 M, while Interest Expense is likely to drop about 60.3 M. Illumina | Select Account or Indicator |
Illumina Company Profit Margin Analysis
Illumina's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Illumina Profit Margin | (0.36) % |
Most of Illumina's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Illumina is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Illumina Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Illumina has a Profit Margin of -0.3611%. This is 96.78% lower than that of the Life Sciences Tools & Services sector and 96.89% lower than that of the Health Care industry. The profit margin for all United States stocks is 71.57% lower than that of the firm.
Illumina Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Illumina's current stock value. Our valuation model uses many indicators to compare Illumina value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Illumina competition to find correlations between indicators driving Illumina's intrinsic value. More Info.Illumina is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Illumina's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Illumina's earnings, one of the primary drivers of an investment's value.Illumina's Earnings Breakdown by Geography
Illumina Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Illumina's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Illumina could also be used in its relative valuation, which is a method of valuing Illumina by comparing valuation metrics of similar companies.Illumina is currently under evaluation in profit margin category among its peers.
Illumina ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Illumina's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Illumina's managers, analysts, and investors.Environmental | Governance | Social |
Illumina Fundamentals
| Return On Equity | -0.4 | ||||
| Return On Asset | 0.0262 | ||||
| Profit Margin | (0.36) % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 23.52 B | ||||
| Shares Outstanding | 158.6 M | ||||
| Shares Owned By Insiders | 0.20 % | ||||
| Shares Owned By Institutions | 99.80 % | ||||
| Number Of Shares Shorted | 5.04 M | ||||
| Price To Earning | 49.12 X | ||||
| Price To Book | 10.25 X | ||||
| Price To Sales | 4.96 X | ||||
| Revenue | 4.5 B | ||||
| Gross Profit | 2.97 B | ||||
| EBITDA | (1.07 B) | ||||
| Net Income | (1.16 B) | ||||
| Cash And Equivalents | 2.01 B | ||||
| Cash Per Share | 6.62 X | ||||
| Total Debt | 2.26 B | ||||
| Debt To Equity | 0.38 % | ||||
| Current Ratio | 0.93 X | ||||
| Book Value Per Share | 13.45 X | ||||
| Cash Flow From Operations | 478 M | ||||
| Short Ratio | 2.40 X | ||||
| Earnings Per Share | (9.92) X | ||||
| Price To Earnings To Growth | 0.62 X | ||||
| Target Price | 161.92 | ||||
| Number Of Employees | 10.59 K | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 21.79 B | ||||
| Total Asset | 10.11 B | ||||
| Retained Earnings | (19 M) | ||||
| Working Capital | 1.04 B | ||||
| Current Asset | 2.1 B | ||||
| Current Liabilities | 610.49 M | ||||
| Net Asset | 10.11 B |
About Illumina Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Illumina's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Illumina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Illumina based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 289.8 M | 304.3 M | |
| Total Revenue | 5.2 B | 5.4 B | |
| Cost Of Revenue | 2 B | 2.1 B | |
| Stock Based Compensation To Revenue | 0.10 | 0.09 | |
| Sales General And Administrative To Revenue | 0.02 | 0.02 | |
| Research And Ddevelopement To Revenue | 0.35 | 0.33 | |
| Capex To Revenue | 0.05 | 0.05 | |
| Revenue Per Share | 25.66 | 26.94 | |
| Ebit Per Revenue | (0.21) | (0.22) |
Pair Trading with Illumina
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.Moving together with Illumina Stock
Moving against Illumina Stock
| 0.46 | DRTS | Alpha Tau Medical | PairCorr |
| 0.43 | VCEL | Vericel Corp Ord | PairCorr |
| 0.39 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.35 | DMAC | DiaMedica Therapeutics | PairCorr |
The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.
The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Illumina Piotroski F Score and Illumina Altman Z Score analysis. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (9.92) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets |
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.